Citadel Advisors
IMDZ

Citadel Advisors’s Immune Design Corp. IMDZ Stock Holding History

Citadel Advisors’s Portfolio IMDZ Stock Details IMDZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-13,000
Closed -$59K – 10165
2018
Q2 		$59K Buy
+13,000
New +$51.8K ﹤0.01% 8409
2016
Q1 		– Sell
-700
Closed -$14K – 9265
2015
Q4 		$14K Buy
+700
New +$12.1K ﹤0.01% 8163

Other funds holding IMDZ

PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citadel Advisors's IMDZ Position: Q4 2018 in Review

Citadel Advisors sold out of Immune Design Corp. (IMDZ) in Q4 2018, closing a stake of 23,912 shares — an estimated $82K sold.

Citadel Advisors first reported a position in IMDZ in Q4 2015 and held it in 3 quarters. The position peaked at $165K in Q2 2018. 64 funds tracked by Wall St. Rank hold IMDZ as of Q4 2018.

  • Citadel Advisors reported no remaining Immune Design Corp. position as of Q4 2018 after selling out during the quarter.
  • Citadel Advisors sold 23,912 Immune Design Corp. shares in Q4 2018, an estimated $82K.
  • Citadel Advisors first reported a position in Immune Design Corp. in Q4 2015 and held it in 3 quarters.
  • Citadel Advisors's Immune Design Corp. position peaked at $165K in Q2 2018.
  • 64 funds tracked by Wall St. Rank held Immune Design Corp. as of Q4 2018.

Based on Citadel Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.